CAMC first in southern West Virginia to implant world’s first neuromodulation device

CHARLESTON, WV (WVNS) — CAMC recently made a groundbreaking achievement in the medical world for being the first health system in southern West Virginia to implant the Barostim™ Baroreflex Activation Therapy.

According to the press release from Dale M. Witte, Communications Strategist from CAMC, the implant is also the world’s first heart failure device to use neuromodulation, meaning it uses the brain and nervous system to improve symptoms of systolic heart failure in patients. The device is also FDA-approved.

The press release continues by explaining that this therapeutic device was made to help heart failure in patients who were not seeing their symptoms improve with previous treatment from other options.

“This innovative, minimally-invasive procedure involves placing a small device under the skin of the chest that sends electrical signals to the carotid artery in the neck. These signals stimulate the baroreceptors, which are pressure sensors that send information to the brain about blood pressure and heart rate. We are thrilled to offer this groundbreaking technology for our patients. To get them back to their normal routine and to improve their quality of life is incredible,” said Dr. Shadi Abu-Halimah, Vascular Surgeon at the CAMC Vascular Center of Excellence.

Procedures for this therapeutic device are very easy to perform on patients, with patients going home after the procedure has been finished.

For more information about CAMC and this procedure, visit camc.org .

For the latest news, weather, sports, and streaming video, head to WVNS.